What did @jacobnach actually say?
The creator claims he is "in the shape of my life" and credits two peptides for the transformation: tesamorelin (what he calls "Tessa hip") and retatrutide (the "hard R"). He says tesamorelin is a growth hormone peptide that "targets visceral fat" and builds muscle. He calls retatrutide "the best fat loss mechanism I have ever seen in my life," claiming it "teaches your body to just burn more calories" and that "theoretically you could change nothing about your diet or your exercise and still lose weight." He also notes mild appetite suppression and gives the combo a 9.6 out of 10 before his protocol is even finished.
This is a personal testimonial from someone using unverified compounds at unknown doses, rating an incomplete experiment. That framing matters a lot before we get into the science.
Does the science back this up?
Tesamorelin has real clinical data behind it. Retatrutide has early-stage human trial data that is genuinely impressive, but calling it proven for general physique use is a stretch. The combo claim, specifically, has zero controlled human evidence.
Tesamorelin is an FDA-approved synthetic GHRH analogue. Its approval is specifically for HIV-associated lipodystrophy, meaning visceral fat reduction in that population. The pivotal Falutz et al. (2010, NEJM) trial showed statistically significant visceral adipose tissue reduction compared to placebo. A follow-up by Stanley et al. (2012, Journal of Clinical Endocrinology and Metabolism) confirmed sustained effects with continued use. The visceral fat targeting claim is real, but muscle-building effects in healthy individuals are modest and context-dependent.
Retatrutide is a GIP/GLP-1/glucagon triple agonist tested in a Phase 2 trial by Jastreboff et al. (2023, NEJM). Participants lost up to 24% body weight over 48 weeks. The mechanism does increase energy expenditure, but "change nothing and still lose weight" wildly oversimplifies a drug that also significantly suppresses appetite and alters gut hormone signaling.
What did they get wrong (or right)?
The visceral fat claim for tesamorelin is accurate in the right population. Give credit where it is due. The appetite suppression note on retatrutide is also consistent with trial data. Those are the honest parts of this video.
Here is where it falls apart. The claim that you can "change nothing about your diet or your exercise and still lose weight" is irresponsible framing. The Jastreboff 2023 trial participants received lifestyle counseling alongside the drug. Real-world weight loss outcomes without dietary context are unknown. More importantly, retatrutide is not approved by the FDA for any indication as of mid-2025. It is investigational. Sourcing it outside a clinical trial almost certainly means compounded or gray-market product with no verified purity or dosing accuracy.
The muscle-building framing also leans harder than the data supports. Tesamorelin raises IGF-1, which has anabolic signaling properties, but a 2014 meta-analysis by Moller et al. (Growth Hormone and IGF Research) found lean mass changes in healthy adults using GHRH analogues are statistically modest. This is not a substitute for resistance training stimulus.
What should you actually know?
If you are considering either of these compounds, the regulatory and safety picture is not optional information. Tesamorelin is FDA-approved as Egrifta, but only for a specific diagnosed condition. Compounded tesamorelin is a different product. Retatrutide has no approved form available outside clinical trials. What is sold in gray markets has no confirmed composition.
The combination has not been studied in healthy adults for body recomposition. Stacking a GHRH analogue with a triple incretin agonist raises questions about insulin sensitivity, cardiovascular strain, and hormonal feedback that a 128K-view TikTok does not address. Retatrutide in particular carries real risks including nausea, vomiting, and heart rate elevation documented in the Phase 2 trial. The creator is two months from finishing his protocol when he filmed this. He does not yet have final results.
Anyone curious about peptide-based approaches to body composition should be working with a licensed provider who can order labs, track IGF-1 and metabolic panels, and actually monitor what is happening internally, not just visually.